130 related articles for article (PubMed ID: 10879745)
1. Over-expression of TSC-22 (TGF-beta stimulated clone-22) markedly enhances 5-fluorouracil-induced apoptosis in a human salivary gland cancer cell line.
Uchida D; Kawamata H; Omotehara F; Miwa Y; Hino S; Begum NM; Yoshida H; Sato M
Lab Invest; 2000 Jun; 80(6):955-63. PubMed ID: 10879745
[TBL] [Abstract][Full Text] [Related]
2. In vivo enhancement of chemosensitivity of human salivary gland cancer cells by overexpression of TGF-beta stimulated clone-22.
Omotehara F; Uchida D; Hino S; Begum NM; Yoshida H; Sato M; Kawamata H
Oncol Rep; 2000; 7(4):737-40. PubMed ID: 10854535
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo.
Nakashiro K; Kawamata H; Hino S; Uchida D; Miwa Y; Hamano H; Omotehara F; Yoshida H; Sato M
Cancer Res; 1998 Feb; 58(3):549-55. PubMed ID: 9458104
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic TSC-22 (transforming growth factor-beta-stimulated clone-22) markedly enhances the radiation sensitivity of salivary gland cancer cells.
Hino S; Kawamata H; Omotehara F; Uchida D; Miwa Y; Begum NM; Yoshida H; Sato M; Fujimori T
Biochem Biophys Res Commun; 2002 Apr; 292(4):957-63. PubMed ID: 11944908
[TBL] [Abstract][Full Text] [Related]
5. Leucine zipper structure of TSC-22 (TGF-beta stimulated clone-22) markedly inhibits the anchorage-independent growth of salivary gland cancer cells.
Hino S; Kawamata H; Omotehara F; Uchida D; Begum NM; Yoshida H; Sato M; Fujimori T
Oncol Rep; 2002; 9(2):371-4. PubMed ID: 11836610
[TBL] [Abstract][Full Text] [Related]
6. Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell.
Kawamata H; Nakashiro K; Uchida D; Hino S; Omotehara F; Yoshida H; Sato M
Br J Cancer; 1998; 77(1):71-8. PubMed ID: 9459148
[TBL] [Abstract][Full Text] [Related]
7. Nuclear translocation of TSC-22 (TGF-beta-stimulated clone-22) concomitant with apoptosis: TSC-22 as a putative transcriptional regulator.
Hino S; Kawamata H; Uchida D; Omotehara F; Miwa Y; Begum NM; Yoshida H; Fujimori T; Sato M
Biochem Biophys Res Commun; 2000 Nov; 278(3):659-64. PubMed ID: 11095965
[TBL] [Abstract][Full Text] [Related]
8. TSC-22 (TGF-beta stimulated clone-22): a novel molecular target for differentiation-inducing therapy in salivary gland cancer.
Kawamata H; Fujimori T; Imai Y
Curr Cancer Drug Targets; 2004 Sep; 4(6):521-9. PubMed ID: 15379637
[TBL] [Abstract][Full Text] [Related]
9. Induction of cyclin-dependent kinase inhibitor, p21WAF1, by treatment with 3,4-dihydro-6-[4-(3,4)-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line with mutant p53 gene.
Sato M; Kawamata H; Harada K; Nakashiro K; Ikeda Y; Gohda H; Yoshida H; Nishida T; Ono K; Kinoshita M; Adachi M
Cancer Lett; 1997 Jan; 112(2):181-9. PubMed ID: 9066726
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of apoptotic cell death of human gastric carcinoma cells mediated by transforming growth factor beta.
Ohta S; Yanagihara K; Nagata K
Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):777-82. PubMed ID: 9210400
[TBL] [Abstract][Full Text] [Related]
11. Expression of a TGF-beta1 inducible gene, TSC-36, causes growth inhibition in human lung cancer cell lines.
Sumitomo K; Kurisaki A; Yamakawa N; Tsuchida K; Shimizu E; Sone S; Sugino H
Cancer Lett; 2000 Jul; 155(1):37-46. PubMed ID: 10814877
[TBL] [Abstract][Full Text] [Related]
12. Characterization of stably transfected fusion protein GFP-estrogen receptor-alpha in MCF-7 human breast cancer cells.
Zhao H; Hart LL; Keller U; Holth LT; Davie JR
J Cell Biochem; 2002; 86(2):365-75. PubMed ID: 12112006
[TBL] [Abstract][Full Text] [Related]
13. A chimeric fusion protein of cytochrome CYP4B1 and green fluorescent protein for detection of pro-drug activating gene delivery and for gene therapy in malignant glioma.
Rainov NG; Sena-Esteves M; Fraefel C; Dobberstein KU; Chiocca EA; Breakefield XO
Adv Exp Med Biol; 1998; 451():393-403. PubMed ID: 10026902
[TBL] [Abstract][Full Text] [Related]
14. Vesnarinone, a differentiation inducing drug, directly activates p21(waf1) gene promoter via Sp1 sites in a human salivary gland cancer cell line.
Omotehara F; Kawamata H; Uchida D; Hino S; Nakashiro K; Fujimori T
Br J Cancer; 2002 Oct; 87(9):1042-6. PubMed ID: 12434298
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor gamma and transforming growth factor-beta pathways inhibit intestinal epithelial cell growth by regulating levels of TSC-22.
Gupta RA; Sarraf P; Brockman JA; Shappell SB; Raftery LA; Willson TM; DuBois RN
J Biol Chem; 2003 Feb; 278(9):7431-8. PubMed ID: 12468551
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta1 inhibits NF-kappaB activity through induction of IkappaB-alpha expression in human salivary gland cells: a possible mechanism of growth suppression by TGF-beta1.
Azuma M; Motegi K; Aota K; Yamashita T; Yoshida H; Sato M
Exp Cell Res; 1999 Jul; 250(1):213-22. PubMed ID: 10388535
[TBL] [Abstract][Full Text] [Related]
17. Effect of p16INK4a on chemosensitivity in nasopharyngeal carcinoma cells.
Chow LS; Wang X; Kwong DL; Sham JS; Tsao SW; Nicholls JM
Int J Oncol; 2000 Jul; 17(1):135-40. PubMed ID: 10853030
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional activation of cyclin-dependent kinase inhibitor, p21waf1 gene by treatment with a differentiation inducing agent, vesnarinone in a human salivary gland cancer cell line.
Omotehara F; Nakashiro K; Uchida D; Hino S; Fujimori T; Kawamata H
J Exp Clin Cancer Res; 2003 Mar; 22(1):57-60. PubMed ID: 12725323
[TBL] [Abstract][Full Text] [Related]
19. Predominant intracellular localization of the type I transforming growth factor-beta receptor and increased nuclear accumulation after growth arrest.
Zwaagstra JC; Guimond A; O'Connor-McCourt MD
Exp Cell Res; 2000 Jul; 258(1):121-34. PubMed ID: 10912794
[TBL] [Abstract][Full Text] [Related]
20. Bax induction activates apoptotic cascade via mitochondrial cytochrome c release and Bax overexpression enhances apoptosis induced by chemotherapeutic agents in DLD-1 colon cancer cells.
Kobayashi T; Sawa H; Morikawa J; Zhang W; Shiku H
Jpn J Cancer Res; 2000 Dec; 91(12):1264-8. PubMed ID: 11123425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
